Presentations

27 February 2012 – Half Year Results
11 January 2012 – Presentation to 30th Annual JP Morgan Healthcare Conference in USA
24 November 2011 - Chief Executive Presentation to AGM
14 November 2011 – Presentation to the American Heart Association by Dr Emerson C. Perin, Texas Heart Institute
9 November 2011 – Credit Suisse Healthcare Conference, Phoenix, Arizona
24 August 2011 – Webcast of Conference Call on 2011 Preliminary Financial Results
http://www.brr.com.au/event/frame/85380
24 August 2011 - Mesoblast Management Presentation
14 June 2011 Presentation to 8th Nomura Asia Equity Forum, Singapore
9 February 2011 CEO Presentation to EGM
29 November, 2010 Shareholder Annual General Meeting (AGM)
14 November 2010 Nomura US Asia Corporation Day
22 September 2010 CEO Presentation to EGM
30 November 2009 Executive Director’s Presentation to the 2009 Annual General Meeting
25 June 2009 Investor Presentation to Australian Institutional Investors and Fund Managers. Executive Director Professor Silviu Itescu

Products

The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...

Find out more

Technology

Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...

Find out more

Clinical trials

Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...

Find out more